Efficacy of hemostatic agents in improving surgical hemostasis

Transfusion Medicine Reviews

Volumn 10, Issue 3, 1996, Pages 171-182

  Green, D ^a   Wong, C A ^a   Twardowski, P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; ASCORBIC ACID; DESMOPRESSIN; ESTROGEN; FIBRIN GLUE; HEMOSTATIC AGENT; VITAMIN K GROUP;

ANAPHYLAXIS; DIARRHEA; DRUG EFFICACY; HEART SURGERY; HEMOPHILIA A; HEMOSTASIS; HOT FLUSH; HUMAN; HYPOTENSION; MUSCLE NECROSIS; MYALGIA; NAUSEA; REVIEW; THROMBOCYTE DISORDER; VON WILLEBRAND DISEASE;

EID: 0030015929     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(96)80058-7     Document Type: Article

References (142)

1. Ratnoff OD Some therapeutic agents influencing hemostasis Colman RW Hirsh J Marder VJ Salzman EW Hemostasis and Thrombosis: Basic Principles and Clinical Practive ed 3 1994 Lippincott Philadelphia, PA 1104 1118
2. Verstraete M Haemostatic drugs Bloom AL Forbes CD Thomas DP Tuddenham EGD Haemostasis and Thrombosis ed 3 1994 Churchill Livingstone Edinburgh, UK 1057 1073
3. McCarthy PM Fibrin glue in cardiothoracic surgery Transfus Med Rev 7 1993 173 179
4. DePalma L Criss VR Luban NL The preparation of fibrinogen concentrate for use as fibrin glue by four different methods Transfus 33 1993 717 720
5. Quigley RL Perkins JA Gottner RJ Intraoperative procurement of autologuosu fibrin glue Ann Thorac Surg 56 1993 387 389
6. Sequin JR Picard E Frapier JM Chaptal PA Aortic valve repair with fibrin glue for type A acute aortic dissection Ann Thorac Surg 58 1994 304 306
7. Saltz R Sierra D Feldman D Experimental and clinical applications of fibrin glue Plast Reconstr Surg 90 1992 726 727
8. Stechison MT Rapid polymerizing fibrin glue from autologous or single-donor blood: Preparation and indications J Neurosurg 76 1992 626 628
9. Kram HB Clark SR Ocampo HP Fibrin glue sealing of pancreatic injuries, resections, and anastemoses Am J Surg 161 1991 479 481
10. Rakocz M Mazar A Varon D Dental extractions in patients with bleeding disorders. The use of fibrin glue Oral Surg Oral Med Oral Pathol 75 1993 280 282
11. Martinowitz U Varon D Jonas P Circumcision in hemophilia: The use of fibrin glue for local hemostasis J Urol 148 1992 855 857
12. Berguer R Staerkel RL Moore FA Warning: Fatal reaction to the use of fibrin glue in deep hepatic wounds. Case report J Trauma 31 1991 408 411
13. Banninger H Hardegger T Tobler A Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V Br J Haematol 85 1993 528 532
14. Stricker RB Lane PK Leffert JD Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves Blood 72 1988 1375 1380
15. Zehnder JL Leung LLK Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin Blood 76 1990 2011 2016
16. Mannucci PM Ruggeri ZM Pareti FI Capitanio A 1-deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrand's disease Lancet 1 1977 869 872
17. Horrow JC Desmopressin and antifibrinolytics Int Anesthesiol Clin 28 1990 230 236
18. Hashemi S Palmer DS Aye MT Ganz PR Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells J Cell Physiol 154 1993 496 505
19. (review) Lethagen S Desmopressin (DDAVP) and hemostasis Ann Hematol 69 1994 173 180
20. Sloand EM Alyono D Klein HG I-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass Am J Hematol 46 1994 199 207
21. Lethagen S Nilsson IM DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa Euro J Haematol 49 1992 7 13
22. Casonato A Pontara E Dannhaeuser D Reevaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease Blood Coagul Fibrinolysis 5 1994 959 964
23. Kobrinsky NL Israels ED Gerrard JM Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders Lancet 1 1984 1145 1148
24. Mannucci PM Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders Blood 72 1988 1449 1455
25. DiMichele DM Hathaway WE Use of DDAVP in inherited and acquired platelet dysfunction Am J Hematol 33 1990 33 45
26. (letter) Kemahli S Canatan D Uysal Z DDAVP shortens bleeding time in Bernard-Soulier syndrome Thromb Haemostas 71 1994 675
27. (letter) Sweeney JD Hoernig LA Behrens AA Bloom ML Hand surgery in Glanzmann's thrombasthenia Am J Hematol 41 1992 140 141
28. Mannucci PM Remuzzi G Pusineri F Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia N Engl J Med 308 1983 8 12
29. Mannucci PM Vicente V Vianello L Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time Blood 67 1967 1148 1153
30. (letter) Lethagen S Rugarn P The effect of DDAVP and placebo on platelet function and prolonged bleeding time induced by oral acetyl salicylic acid intake in healthy volunteers Thromb Haemostas 67 1992 185 186
31. Flordal PA Sahlin S Use of desmopressin to prevent bleeding complications in patients treated with aspirin Br J Surg 80 1993 723 724
32. Schulman S Johnsson H Heparin, DDAVP and the bleeding time Thromb Haemostas 65 1991 242 244
33. Shiffrin JS Glass DD DDAVP administration for postbypass bleeding, pro: Desmopressin is of value in the treatment of post-cardiopulmonary bypass bleeding J Cardiothorac Vasc Anesth 5 1991 285 289
34. Salzman EW Weinstein MJ Weintraub RM Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial N Engl J Med 314 1986 1402 1406
35. Marquez J Koehler S Strelec SR Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: A prospective, blinded, randomized study J Cardiothorac Vasc Anesth 6 1992 674 676
36. Rocha E Hidalgo F Llorens R Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery Circulation 90 1994 921 927
37. Horrow JC Van Riper DF Strong MD Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery Circulation 84 1991 2063 2070
38. Mongan PD Hosking MP The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification Anesthesiology 77 1992 38 46
39. Sheridan DP Card RT Pinilla JC Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction Can J Surg 37 1994 33 36
40. Gratz I Koehler J Olsen D The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations J Thorac Cardiovasc Surg 104 1992 1417 1422
41. Dilthey G Dietrich W Spannagl M Influence of desmopressin acetate on homologous blood requirements in J Cardiothorac Vasc Anesth 7 1993 425 430
42. Seear MD Wadsworth LD Rogers PC The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children J Thorac Cardiovasc Surg 98 1989 217 219
43. Reynolds LM Nicolson SC Jobes DR Desmopressin does not decrease bleeding after cardiac operation in young children J Thorac Cardiovasc Surg 106 1993 954 958
44. (letter) Cartaneo M Mannucci PM Desmopressin and blood loss after cardiac surgery Lancet 342 1993 812
45. Fremes SE Wong BI Lee E Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding Ann Thorac Surg 58 1994 1580 1588
46. Kobrinsky NL Letts RM Patel LR 1-desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery Ann Intern Med 107 1987 446 450
47. Guay J Reinberg C Poitras B A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis [see comments] Anesth Analg 75 1992 405 410
48. Flordal PA Ljungstrom KG Ekman B Neander G Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients Acta Orthop Scand 63 1992 381 385
49. Karnezis TA Stulberg SD Wixson RL Reilly P The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial J Bone Joint Surg [Am] 76 1994 1545 1550
50. Wingate GF Lewis V Jr Green D Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores Plastic Reconstr Surg 89 1992 279 282
51. Haith L Jr Patton ML Goldman WT Diminishing blood loss during operation for burns Surg Gynecol Obstet 176 1993 119 123
52. Lethagen S Rugarn P Bergqvist D Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery Euro J Vasc Surg 5 1991 173 178
53. Kang Y Scott V DeWolf A In vitro effects of DDAVP during liver transplantation Trans Proc 25 1993 1821 1822
54. Lethagen S Harris AS Sjorin E Intranasal and intravenous administration of desmopressin: Effect on F VIII/vWF, pharmacokinetics and reproducibility Thromb Haemost 58 1987 1033 1036
55. Mannucci PM Vicente V Alberca I Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: Pharmacokinetics and factor VIII responses Thromb Haemost 58 1987 1037 1039
56. Richardson DW Robinson AG Desmopressin Ann Intern Med 103 1985 228 239
57. Johns RA Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbit and rat Anesthesiology 72 1990 858 864
58. Takahashi H Tatewaki W Wada K Plasmin generation and fibrin(ogen)olysis following desmopressin infusion Am J Hematol 36 1991 255 258
59. Hartmann S Reinhart W Fatal complication of desmopressin Lancet 345 1995 1302
60. (letter) Grunwald Z Sather SD Intraoperative cerebral infarction after desmopressin administration in infant with end-state renal disease Lancet 345 1995 1364 1365
61. Mannucci PM Carlsson S Harris AS Desmopressin, surgery and thrombosis Thromb Haemostas 71 1994 154 155
62. Itabashi A Katayama S Yamaji T Hypersensitivity to chlorobutanol in DDAVP solution Lancet 1 1982 108
63. Gordon EM Douglas JG Ratnoff OD The influence of estrogen and prolactin on hageman factor (factor XII) titer in ovariectomized and hypophysectomized rats Blood 66 1985 602 605
64. Kroon U Silfverstolpe G Tengborn L The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables Thromb Haemostas 71 1994 420 423
65. Harrison RL McKee PA Estrogen stimulate von Willebrand factor production by cultured endothelial cells Blood 63 1984 657 665
66. Caine YG Bauer KA Berzegar S Coagulation activation following estrogen administration to postmenopausal women Thromb Haemostas 68 1992 392 395
67. Alkjaersig N Fletcher AP de Ziegler D Blood coagulation in postmenopausal women given estrogen treatment: Comparison of transdermal and oral administration J Lab Clin Med 111 1988 224 228
68. Livio M Mannucci PM Vigano G Conjugated estrogens for the management of bleeding associated with renal failure N Engl J Med 315 1986 731 735
69. van Cutsem E Rutgeerts P Vantrappen G Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone Lancet 335 1990 953 955
70. Bronner MH Pate MB Cunningham JT Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure Ann Intern Med 105 1986 371 374
71. Alperin JB Estrogens and surgery in women with von Willebrand's disease Am J Med 73 1982 367 371
72. Trautschold I Werle E Zickgraf-Rudel G Trasylol Biochem Pharmacol 16 1967 59 72
73. Fritz H Wunderer G Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs Drug Res 33 1983 479 494
74. Green D Sanders J Eiken M Recombinant aprotinin in coronary artery bypass graft operations J Thorac Cardiovasc Surg 110 1995 963 970
75. Royston D Bidstrup BP Taylor KM Effect of aprotinin on the need for blood transfusion after repeat open heart surgery Lancet 2 1987 1289 1291
76. Bick RL Physiology and pathophysiology of hemostasis during cardiac surgery Pifarre R Blood Conservation with Aprotinin ed 1 1995 Hanley and Belfus Philadelphia, PA 1 44
77. Ray MJ Hawson GAT Just SJE Relationship of platelet aggregation to bleeding after cardiopulmonary bypass Ann Thorac Surg 57 1994 981 986
78. Marengo-Rowe AJ Leveson JE Fibrinolysis: A frequent cause of bleeding Ellison N Jobes DR Effective hemostasis in cardiac surgery ed 1 1988 Saunders Philadelphia, PA 41 55
79. Blauhut B Gross C Necek S Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass J Thorac Cardiovasc Surg 101 1991 958 967
80. Havel M Teufelsbauer H Knobl P Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operations J Thorac Cardiovasc Surg 101 1991 968 972
81. Van Oeveren W Harder MP Roozendal KJ Aprotinin protects platelets against the initial effect of cardiopulmonary bypass J Thorac Cardiovasc Surg 99 1990 788 797
82. Matzdorf AC Green D Cohen I Effect of recombinant aprotinin on platelet activation in patients undergoing open heart surgery Hemostasis 23 1993 293 300
83. Akhtar TM Goodchild C Boyan MKG Reversal of streptokinase-induced bleeding with aprotinin for emergency cardiac surgery Anaesthesia 47 1992 226 228
84. (suppl) Bidstrup B Royston D Mc Guinness C Aprotinin in aspirin-pretreated patients Perfusion 5 1990 77 81
85. Murkin J Lux J Shannon RN Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operation J Thorac Cardiovasc Surg 107 1994 554 561
86. Concha M Munoz I Experience with low-dose Aprotinin Pifarre R Blood Conservation with Aprotinin ed 1 1995 Hanley and Belfus Philadelphia, PA 306 307
87. Cosgrove D Heric B Lytle B Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study Ann Thorac Surg 54 1992 1031 1038
88. Leskiw U Levy J Antigenicity of protamine and aprotinin in cardiac surgery Pifarre R Blood Conservation with Aprotinin ed 1 1995 Hanley and Belfus Philadelphia, PA 253 266
89. Havel M Grabenwoger F Schneider J Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood J Thorac Cardiovasc Surg 107 1994 807 810
90. Bidstrup BP Underwood R Sapsford RN Effect of aprotinin in aorta-coronary bypass graft patency J Thorac Cardiovasc Surg 105 1993 147 153
91. Wang JS Lin CY Hung WT Monitoring of heparin-induced anticoagulation with kaolin-activated clotting times in cardiac surgical patients treated with aprotinin Anesthesiology 77 1992 1080 1084
92. Scudamore C Randall T Shackleton C Aprotinin reduces the need for blood products during liver transplantation Am J Surg 169 1995 546 549
93. Murkin J Blood Conservation and Thromboembolic Disease after Aprotinin Use for Complex Total Hip Arthroplasty Pifarre R Blood Conservation with Aprotinin ed 1 1995 Hanley and Belfus Philadelphia, PA 373 389
94. Soslau G Horrow J Brodsky I Effect of tranexamic acid on platelet ADP during extracorporeal circulation Am J Hematol 38 1991 113 119
95. (review) Hardy JF Belisle S Natural and synthetic antifibrinolytics in adult cardia surgery: Efficacy, effectiveness and efficiency Can J Anaesth 41 1994 1104 1112
96. (letter) Horrow J Strong MD Van Riper DF Tranexamic acid after bypass: Too late to help? J Thorac Cardiovasc Surg 107 1994 1375 1377
97. Horrow JC Hlavacek J Strong MD Prophylactic tranexamic acid decreases bleeding after cardiac operations J Thorac Cardiovasc Surg 99 1990 70 74
98. Horrow JC Van Riper DF Strong MD The dose-response relationship of tranexamic acid Anesthesiology 82 1995 383 592
99. Yau TM Carson S Weisel RD The effect of warm heart surgery on postoperative bleeding J Thorac Cardiovasc Surg 103 1992 1155 1162
100. Rousou JA Engelman RM Tranexamic acid significantly reduces blood loss associated with coronary revascularization Ann Thorac Surg 59 1995 671 675
101. Speekenbrink RG Vonk AB Wildevuur CR Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting Ann Thorac Surg 59 1995 438 442
102. Ovrum E Am Holen E Abdelnoor M Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations J Thorac Cardiovasc Surg 105 1993 78 83
103. Vander Salm TJ Ansell JE Okike ON The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study J Thorac Cardiovasc Surg 95 1988 538 540
104. DelRossi AJ Cernaianu AC Botros S Prophylactic treatment of postperfusion bleeding using EACA Chest 96 1989 27 30
105. Karski JM Teasdale SJ Norman PH Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid J Cardiothorac Vasc Anesth 7 1993 431 435
106. Blauhut B Harringer W Bettelheim P Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J Thorac Cardiovasc Surg 108 1994 1083 1091
107. Stern NS Primary fibrinolysis after oral surgery J Oral Surg 33 1975 49 52
108. Williamson R Eggleston DJ DDAVP and EACA used for minor oral surgery in von Willebrand disease Austr Dent J 33 1988 32 36
109. Sindet-Pedersen S Stenbjerg S Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery J Oral Maxillofac Surg 44 1986 703 707
110. Berliner S Horowitz I Martinowitz U Dental surgery in patients with severe factor XI deficiency without plasma replacement Blood Coag Fibrinol 3 1992 465 468
111. Hasson DM Poole AE deleFuernte B The dental management of patients with spontaneous acquired factor VIII inhibitors JADA 113 1986 633 636
112. Borea G Montebugnoli L Capuzzi P Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discotinuing anticoagulant therapy Oral Surg, Oral Med, Oral Pathol 75 1993 29 31
113. Ramstrom G Sindet-Pedersen S Hall G Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants J Oral Maxillofac Surg 51 1993 1211 1216
114. Flanigan RC Butler KM O'Neal W Comparison of epsilon aminocaproic acid and normal saline for postoperative bladder irrigation following transurethral resection of prostate Urology 26 1985 227 228
115. Sharifi R Lee M Ray P Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate Urology 27 1986 214 219
116. Kang YG Lewis JH Navalgund A Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation Anesthesiology 66 1987 766 773
117. McSorley MW Taraporewalla KJ Does prophylactic epsilon-aminocaproic acid improve blood loss and coagulation in liver transplantation? Trans Proceed 23 1991 1941
118. Oertli D Laffer U Haberthuer F Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer Br J Surg 81 1994 856 859
119. Kopitnik TA Samson DS Management of subarachnoid haemorrhage J Neurol, Neurosurg, Psych 56 1993 947 959
120. Tsementzis SA Meyer CH Hitchcock ER Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid Neurochirurg 35 1992 74 78
121. Glick R Green D Ts'ao C High dose Σ-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage Neurosurg 9 1981 398 401
122. Kane MJ Silverman LR Rand JH Myonecrosis as a complication of the use of epsilon aminocaproic acid: A case report and review of the literature Am J Med 85 1988 861 863
123. Schultz M van der Lelie H Microscopic haematuria as a relative contraindication for tranexamic acid Br J Haematol 89 1995 663 664
124. Dentz ME Slaughter TF Mark JB Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid Anesthesiology 82 1995 583 586
125. Green D Disorders of the vitamin K-dependent coagulation factors E Beutler MA Lichtman BS Coller TJ Kipps Williams Hematology ed 5 1995 McGraw Hill New York, NY 1481 1485
126. White RH McKittrick T Hutchinson R Twitchell J Temporary discontinuation of warfarin therapy: Changes in the international normalized ratio Ann Intern Med 122 1995 40 42
127. Rocha E Llorens R Paramo JA Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 77 1988 1319 1323
128. Brown MR Swygert TH Whitten CW Desmopressin acetate following cardiopulmonary bypass: Evaluation of coagulation parameters J Cardiothorac Vasc Anesth 3 1989 726 729
129. Hackmann T Gascoyne RD Naiman SC A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery N Engl J Med 321 1989 1437 1443
130. Andersson TLG Solem JO Tengborn L Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation Circulation 81 1990 872 878
131. Hedderich GS Petsikas DJ Cooper BA Desmopressin acetate in uncomplicated coronary artery bypass surgery: A prospective randomized clinical trial Can J Surg 33 1990 33 36
132. Frankville DD Harper GB Lake CL Johns RA Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass Anesth 74 1991 988 996
133. Reich DL Hammerschlag BC Rand JH Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures J Cardiothorac Vasc Anesth 5 1991 142 145
134. Salmenpera M Kuitunen A Hynynen M Heinonen J Hemodynamic responses to desmopressin acetate after CABG: A double-blind trial J Cardiothorac Vasc Anesth 5 1991 146 149
135. Hackmann T Gascoyne RD Naiman SC A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery N Engl J Med 321 1989 1437 1443
136. de Prost D Barbier-Boehm G Hazebroucq J Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass Thromb Haemostas 68 1992 106 110
137. Kuitunen AH Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery Ann Chirurg et Gynaecol 81 1992 11 18
138. (review) Temeck BK Bachenheimer LC Katz NM Desmopressin acetate in cardiac surgery: A double-blind, randomized study Southern Med J 87 1994 611 615
139. Dietrich W Barankay A Hahnel C Richter JA High dose aprotinin in cardiac surgery: Three years' experience in 1.784 patients J Cardiothorac Vasc Anaesth 6 1992 324 327
140. Biagini A Comte C Russo V Salerno ML High-dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery Acta Anaesth Belg 43 1992 181 188
141. (suppl) Dementieva Il Dzemeshkevich SL The use of high doses of aprotinin to decrease blood loss in aortocoronary bypass surgery J Cardiovasc Surg 35 1994 185 186
142. Daily PO Lamphere JA Dembitsky WP Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study J Thorac Cardiovasc Surg 108 1994 99 106